Axena Health Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 47

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $15M

  • Investors
  • 9

Axena Health General Information

Description

Developer of a connected medical device designed to improve outcomes for women with pelvic floor disorders. The company's platform offers a novel, effective, first-line treatment for urinary incontinence (UI) and chronic fecal incontinence (FI), underreported conditions, its patented technology enables non-invasive, drug-free treatment via precise visualization of movement in real-time while monitoring usage and progress, enabling women to strengthen their pelvic floor and decrease the symptoms of stress, mixed and urgency incontinence, including overactive bladder.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2120 Commonwealth Avenue
  • Suite 1
  • Newton, MA 02466
  • United States
+1 (855)
Primary Industry
Therapeutic Devices
Other Industries
Diagnostic Equipment
Monitoring Equipment
Corporate Office
  • 2120 Commonwealth Avenue
  • Suite 1
  • Newton, MA 02466
  • United States
+1 (855)

Axena Health Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Axena Health Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series B) 21-May-2026 $15M Completed Generating Revenue
3. Accelerator/Incubator 08-Oct-2025 Completed Generating Revenue
2. Early Stage VC (Series A) 29-May-2024 $30.8M $30.8M Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Axena Health’s complete valuation and funding history, request access »

Axena Health Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-1
Series B
Series A 30,800,000 $0.000100 8% $1 $1 1x $1 48.5%
To view Axena Health’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Axena Health Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a connected medical device designed to improve outcomes for women with pelvic floor disorders. The company'
Therapeutic Devices
Newton, MA
47 As of 2025

Eagan, MN
 

Marlborough, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Axena Health Competitors (12)

One of Axena Health’s 12 competitors is Pelvital USA, a Venture Capital-Backed company based in Eagan, MN.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pelvital USA Venture Capital-Backed Eagan, MN
Boston Scientific Corporation Marlborough, MA
BlueWind Medical Venture Capital-Backed Salt Lake City, UT
Axonics Formerly VC-backed Irvine, CA
Avation Medical Venture Capital-Backed Columbus, OH
You’re viewing 5 of 12 competitors. Get the full list »

Axena Health Patents

Axena Health Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025171302-A1 Devices, systems, and methods for treating a pelvic floor disorder Pending 08-Feb-2024
CA-3179037-A1 Medical device radio frequency transceiver and methods of use thereof Pending 19-May-2020
EP-4154409-A1 Medical device radio frequency transceiver and methods of use thereof Pending 19-May-2020
EP-4154409-A4 Medical device radio frequency transceiver and methods of use thereof Pending 19-May-2020
US-20230201660-A1 Medical device radio frequency transceiver and methods of use thereof Pending 19-May-2020 A63B23/20
To view Axena Health’s complete patent history, request access »

Axena Health Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Axena Health Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
BNP Paribas Asset Management Asset Manager Minority
Mayo Clinic Ventures Corporate Venture Capital Minority
AARP Corporation
Avestria Ventures Venture Capital Minority
AXA Investment Managers Asset Manager Minority
You’re viewing 5 of 9 investors. Get the full list »

Axena Health FAQs

  • When was Axena Health founded?

    Axena Health was founded in 2023.

  • Where is Axena Health headquartered?

    Axena Health is headquartered in Newton, MA.

  • What is the size of Axena Health?

    Axena Health has 47 total employees.

  • What industry is Axena Health in?

    Axena Health’s primary industry is Therapeutic Devices.

  • Is Axena Health a private or public company?

    Axena Health is a Private company.

  • What is the current valuation of Axena Health?

    The current valuation of Axena Health is .

  • What is Axena Health’s current revenue?

    The current revenue for Axena Health is .

  • How much funding has Axena Health raised over time?

    Axena Health has raised $45.8M.

  • Who are Axena Health’s investors?

    BNP Paribas Asset Management, Mayo Clinic Ventures, AARP, Avestria Ventures, and AXA Investment Managers are 5 of 9 investors who have invested in Axena Health.

  • Who are Axena Health’s competitors?

    Pelvital USA, Boston Scientific, BlueWind Medical, Axonics, and Avation Medical are some of the 12 competitors of Axena Health.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process